Multiple Machine-Learning Fusion Model Based on Gd-EOB-DTPA-Enhanced MRI and Aminotransferase-to-Platelet Ratio and Gamma-Glutamyl Transferase-to-Platelet Ratio to Predict Microvascular Invasion in Solitary Hepatocellular Carcinoma: A Multicenter Study

References

• Calderaro J, Seraphin TP, Luedde T, Simon TG. Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma. J Hepatol. 2022;76(6):1348–1361. doi:10.1016/j.jhep.2022.01.014
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450–1462. doi:10.1056/NEJMra1713263
   PubMed Web of Science ®Google Scholar
• Lahan-Martins D, Perales SR, Gallani SK, et al. Microvascular invasion in hepatocellular carcinoma: is it predictable with quantitative computed tomography parameters? Radiol Bras. 2019;52(5):287–292. doi:10.1590/0100-3984.2018.0123
   PubMedGoogle Scholar
• Pommergaard HC, Rostved AA, Adam R, et al. Vascular invasion and survival after liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry. HPB. 2018;20(8):768–775. doi:10.1016/j.hpb.2018.03.002
   PubMed Web of Science ®Google Scholar
• Sheng X, Ji Y, Ren GP, et al. A standardized pathological proposal for evaluating microvascular invasion of hepatocellular carcinoma: a multicenter study by LCPGC. Hepatol Int. 2020;14(6):1034–1047. doi:10.1007/s12072-020-10111-4
   PubMed Web of Science ®Google Scholar
• Hong SB, Choi SH, Kim SY, et al. MRI features for predicting microvascular invasion of Hepatocellular Carcinoma: a systematic review and meta-analysis. Liver Cancer. 2021;10(2):94–106. doi:10.1159/000513704
   PubMed Web of Science ®Google Scholar
• Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317–370. doi:10.1007/s12072-017-9799-9
   PubMed Web of Science ®Google Scholar
• Lee S, Kang TW, Song KD, et al. Effect of microvascular invasion risk on early recurrence of Hepatocellular Carcinoma after surgery and radiofrequency ablation. Ann Surg. 2021;273(3):564–571. doi:10.1097/SLA.0000000000003268
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Te HS, Verna EC, Desai AP. A national survey of hepatocellular carcinoma surveillance practices following liver transplantation. Transplant Direct. 2021;7(1):e638. doi:10.1097/TXD.0000000000001086
   PubMed Web of Science ®Google Scholar
• Nitta H, Allard MA, Sebagh M, et al. Predictive model for microvascular invasion of hepatocellular carcinoma among candidates for either hepatic resection or liver transplantation. Surgery. 2019;165(6):1168–1175. doi:10.1016/j.surg.2019.01.012
   PubMed Web of Science ®Google Scholar
• Hwang S, Lee YJ, Kim KH, et al. The impact of tumor size on long-term survival outcomes after resection of solitary Hepatocellular carcinoma: single-institution experience with 2558 patients. J Gastrointest Surg. 2015;19(7):1281–1290. doi:10.1007/s11605-015-2849-5
   PubMed Web of Science ®Google Scholar
• Erstad DJ, Tanabe KK. Prognostic and therapeutic implications of microvascular invasion in Hepatocellular Carcinoma. Ann Surg Oncol. 2019;26(5):1474–1493. doi:10.1245/s10434-019-07227-9
   PubMed Web of Science ®Google Scholar
• Yuan E, Chen Y, Song B. Quality of radiomics for predicting microvascular invasion in hepatocellular carcinoma: a systematic review. Eur Radiol. 2023;33(5):3467–3477. doi:10.1007/s00330-023-09414-5
   PubMed Web of Science ®Google Scholar
• Xue TC, Jia QA, Ge NL, et al. The platelet-to-lymphocyte ratio predicts poor survival in patients with huge hepatocellular carcinoma that received transarterial chemoembolization. Tumour Biol. 2015;36(8):6045–6051. doi:10.1007/s13277-015-3281-x
   PubMedGoogle Scholar
• Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493–e503. doi:10.1016/S1470-2045(14)70263-3
   PubMed Web of Science ®Google Scholar
• Sanghera C, Teh JJ, Pinato DJ. The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma. Liver Int. 2019;39(11):2008–2023. doi:10.1111/liv.14220
   PubMed Web of Science ®Google Scholar
• Xu X, Sun S, Liu Q, Liu X, Wu F, Shen C. Preoperative application of systemic inflammatory biomarkers combined with MR imaging features in predicting microvascular invasion of hepatocellular carcinoma. Abdom Radiol. 2022;47(5):1806–1816. doi:10.1007/s00261-022-03473-w
   PubMed Web of Science ®Google Scholar
• Li P, Huang W, Wang F, et al. Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma. Biosci Rep. 2018;38(6):BSR20180464. doi:10.1042/BSR20180464
   PubMed Web of Science ®Google Scholar
• Gu Y, Zheng F, Zhang Y, Qiao S. Novel nomogram based on inflammatory markers for the preoperative prediction of microvascular invasion in solitary primary Hepatocellular Carcinoma. Cancer Manag Res. 2022;14:895–907. doi:10.2147/CMAR.S346976
   PubMed Web of Science ®Google Scholar
• Ji F, Liang Y, Fu SJ, et al. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI). BMC Cancer. 2016;16:137. doi:10.1186/s12885-016-2189-1
   PubMed Web of Science ®Google Scholar
• Lai L, Su T, Liang Z, et al. Development and assessment of novel predictive nomograms based on APRI for Hepatitis B virus-associated small solitary Hepatocellular Carcinoma with stereotactic body radiotherapy. J Cancer. 2020;11(22):6642–6652. doi:10.7150/jca.47291
   PubMed Web of Science ®Google Scholar
• Zhang X, Xin Y, Yang Y, et al. Aspartate aminotransferase-to-platelet ratio index for predicting late recurrence of hepatocellular carcinoma after radiofrequency ablation. Int J Hyperthermia. 2022;39(1):437–445. doi:10.1080/02656736.2022.2043457
   PubMed Web of Science ®Google Scholar
• Ma C, Wang N, Ma H, Song K, Yu R, Chen H. Serum gamma-glutamyl transpeptidase-to-platelet ratio (GPR) can predict the prognosis of hepatocellular carcinoma: a meta-analysis and systematic review. Transl Cancer Res. 2022;11(4):745–753. doi:10.21037/tcr-21-2559
   PubMed Web of Science ®Google Scholar
• Yang D, Wu H, Nong W, et al. A new model based on gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts prognostic outcome after curative resection of solitary hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 2021;45(5):101509. doi:10.1016/j.clinre.2020.07.014
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jin F, Wu Y, et al. Prognostic impact of gamma-glutamyl transpeptidase to platelets ratio on hepatocellular carcinoma patients who have undergone surgery: a meta-analysis and systematic review. Eur J Gastroenterol Hepatol. 2023;35(8):803–811. doi:10.1097/MEG.0000000000002572
   PubMed Web of Science ®Google Scholar
• Feng ST, Jia Y, Liao B, et al. Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI. Eur Radiol. 2019;29(9):4648–4659. doi:10.1007/s00330-018-5935-8
   PubMed Web of Science ®Google Scholar
• Lee S, Kim SH, Lee JE, Sinn DH, Park CK. Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol. 2017;67(3):526–534. doi:10.1016/j.jhep.2017.04.024
   PubMed Web of Science ®Google Scholar
• Ueno A, Masugi Y, Yamazaki K, et al. OATP1B3 expression is strongly associated with Wnt/β-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma. J Hepatol. 2014;61(5):1080–1087. doi:10.1016/j.jhep.2014.06.008
   PubMed Web of Science ®Google Scholar
• Du M, Chen L, Zhao J, et al. Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma. BMC Cancer. 2014;14:38. doi:10.1186/1471-2407-14-38
   PubMed Web of Science ®Google Scholar
• Ngiam KY, Khor IW. Big data and machine learning algorithms for health-care delivery. Lancet Oncol. 2019;20(5):e262–e273. doi:10.1016/S1470-2045(19)30149-4
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhu T, Zhang X, et al. Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study. EClinicalMedicine. 2023;58:101899. doi:10.1016/j.eclinm.2023.101899
   PubMedGoogle Scholar
• Onozato Y, Iwata T, Uematsu Y, et al. Predicting pathological highly invasive lung cancer from preoperative [18F]FDG PET/CT with multiple machine learning models. Eur J Nucl Med Mol Imaging. 2023;50(3):715–726. doi:10.1007/s00259-022-06038-7
   PubMed Web of Science ®Google Scholar
• Mao S, Yu X, Shan Y, Fan R, Wu S, Lu C. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-based nomogram model to predict tumor recurrence of AFP-negative Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2021;8:1355–1365. doi:10.2147/JHC.S339707
   PubMed Web of Science ®Google Scholar
• Yang L, Gu D, Wei J, et al. A radiomics nomogram for preoperative prediction of microvascular invasion in Hepatocellular Carcinoma. Liver Cancer. 2019;8(5):373–386. doi:10.1159/000494099
   PubMed Web of Science ®Google Scholar
• Okamura S, Sumie S, Tonan T, et al. Diffusion-weighted magnetic resonance imaging predicts malignant potential in small hepatocellular carcinoma. Dig Liver Dis. 2016;48(8):945–952. doi:10.1016/j.dld.2016.05.020
   PubMedGoogle Scholar
• Giavarina D. Understanding Bland Altman analysis. Biochem Med. 2015;25(2):141–151. doi:10.11613/BM.2015.015
   PubMed Web of Science ®Google Scholar
• Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–163. doi:10.1016/j.jcm.2016.02.012
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi:10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Okuda M, Li K, Beard MR, et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology. 2002;122(2):366–375. doi:10.1053/gast.2002.30983
   PubMed Web of Science ®Google Scholar
• Ma H, Zhang L, Tang B, et al. γ-Glutamyl transpeptidase is a prognostic marker of survival and recurrence in radiofrequency-ablation treatment of hepatocellular carcinoma. Ann Surg Oncol. 2014;21(9):3084–3089. doi:10.1245/s10434-014-3724-4
   PubMed Web of Science ®Google Scholar
• Fu SJ, Zhao Q, Ji F, et al. Elevated preoperative serum gamma-glutamyltranspeptidase predicts poor prognosis for Hepatocellular Carcinoma after liver transplantation. Sci Rep. 2016;6:28835. doi:10.1038/srep28835
   PubMed Web of Science ®Google Scholar
• Gauglhofer C, Sagmeister S, Schrottmaier W, et al. Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis. Hepatology. 2011;53(3):854–864. doi:10.1002/hep.24099
   PubMed Web of Science ®Google Scholar
• Kitao A, Matsui O, Yoneda N, et al. The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. Eur Radiol. 2011;21(10):2056–2066. doi:10.1007/s00330-011-2165-8
   PubMed Web of Science ®Google Scholar
• Tang M, Zhou Q, Huang M, et al. Nomogram development and validation to predict hepatocellular carcinoma tumor behavior by preoperative gadoxetic acid-enhanced MRI. Eur Radiol. 2021;31(11):8615–8627. doi:10.1007/s00330-021-07941-7
   PubMed Web of Science ®Google Scholar
• Hu H, Zheng Q, Huang Y, et al. A non-smooth tumor margin on preoperative imaging assesses microvascular invasion of hepatocellular carcinoma: a systematic review and meta-analysis. Sci Rep. 2017;7(1):15375. doi:10.1038/s41598-017-15491-6
   PubMed Web of Science ®Google Scholar
• Zhou YM, Yang JM, Li B, et al. Risk factors for early recurrence of small hepatocellular carcinoma after curative resection. Hepatobiliary Pancreat Dis Int. 2010;9(1):33–37.
   PubMed Web of Science ®Google Scholar
• Giuliante F, Ardito F, Pinna AD, et al. Liver resection for hepatocellular carcinoma ≤3 cm: results of an Italian multicenter study on 588 patients. J Am Coll Surg. 2012;215(2):244–254. doi:10.1016/j.jamcollsurg.2012.04.013
   PubMed Web of Science ®Google Scholar
• Fukuda S, Itamoto T, Nakahara H, et al. Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma. Hepatogastroenterology. 2005;52(64):1163–1167.
   PubMedGoogle Scholar
• Shindoh J, Andreou A, Aloia TA, et al. Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors. Ann Surg Oncol. 2013;20(4):1223–1229. doi:10.1245/s10434-012-2739-y
   PubMed Web of Science ®Google Scholar
• Xu P, Zeng M, Liu K, Shan Y, Xu C, Lin J. Microvascular invasion in small hepatocellular carcinoma: is it predictable with preoperative diffusion-weighted imaging? J Gastroenterol Hepatol. 2014;29(2):330–336. doi:10.1111/jgh.12358
   PubMed Web of Science ®Google Scholar